These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9278940)

  • 1. [Relationship between cholinergic symptoms caused by distigmine and the activities of serum AChE and BChE].
    Koga M; Miyata H; Tsuno N; Nakayama K; Ushijima S; Tanaka Y; Hiraga Y; Kobayashi N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Jun; 17(3):143-7. PubMed ID: 9278940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between Distigmine-induced Adverse Events and Serum Butyrylcholinesterase Level: A Multicenter Retrospective Study].
    Mitsuboshi S; Otaki S; Kaneko C; Tsuruma N
    Yakugaku Zasshi; 2022; 142(9):993-998. PubMed ID: 36047226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood acetylcholinesterase and butyrylcholinesterase as biomarkers of cholinesterase depression among pesticide handlers.
    Strelitz J; Engel LS; Keifer MC
    Occup Environ Med; 2014 Dec; 71(12):842-7. PubMed ID: 25189163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of distigmine bromide on the central cholinergic system.
    Nakayama K; Katsu H; Kitazumi K
    J Psychopharmacol; 2009 Mar; 23(2):190-3. PubMed ID: 18515453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal hypersalivation caused by distigmine bromide in a patient with multiple system atrophy.
    Suzuki K; Miyamoto T; Miyamoto M; Hirata K
    Intern Med; 2008; 47(10):983-4. PubMed ID: 18480587
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic analysis of acetylcholinesterase inhibition by distigmine bromide in rats.
    Ito Y; Harada T; Fushimi K; Kagawa Y; Oka H; Nakazawa H; Homma R; Kato Y; Yamada S
    Drug Metab Pharmacokinet; 2010; 25(3):254-61. PubMed ID: 20610884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute respiratory failure associated with cholinergic crisis: report of five cases and review of the literature].
    Takahashi M; Ubukata S; Sato E; Shoji M; Morikawa N; Watanabe H; Takahashi H
    Nihon Kokyuki Gakkai Zasshi; 2011 Dec; 49(12):877-84. PubMed ID: 22352046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.
    Ben Anes A; Ben Nasr H; Garrouch A; Bennour S; Bchir S; Hachana M; Benzarti M; Tabka Z; Chahed K
    Mol Cell Biochem; 2018 Aug; 445(1-2):1-11. PubMed ID: 29234928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Duysen EG; Li B; Darvesh S; Lockridge O
    Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholinesterase and butyrylcholinesterase activities in obese Beagle dogs before and after weight loss.
    Tvarijonaviciute A; Ceron JJ; Tecles F
    Vet Clin Pathol; 2013 Jun; 42(2):207-11. PubMed ID: 23550593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cholinergic crisis following administration of distigmine bromide: a case report].
    Yamanaka S; Fujita I; Murota T; Kawakita M; Matsuda T
    Hinyokika Kiyo; 2002 Jan; 48(1):21-3. PubMed ID: 11868380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment].
    Kobayashi K; Sekiguchi H; Sato N; Hirose Y
    Chudoku Kenkyu; 2016 Mar; 29(1):26-9. PubMed ID: 27255021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Patient Age, Dose, and Chronic Kidney Disease on the Risk of Adverse Reactions to Distigmine.
    Mitsuboshi S; Nagai K; Okajima H
    Biol Pharm Bull; 2020; 43(8):1275-1278. PubMed ID: 32741950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable response of cholinesterase activities following human exposure to different types of organophosphates.
    Moon J; Chun B; Lee S
    Hum Exp Toxicol; 2015 Jul; 34(7):698-706. PubMed ID: 25712411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays.
    Haigh JR; Lefkowitz LJ; Capacio BR; Doctor BP; Gordon RK
    Chem Biol Interact; 2008 Sep; 175(1-3):417-20. PubMed ID: 18555983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of methods used for the determination of cholinesterase activity in whole blood.
    Naik RS; Doctor BP; Saxena A
    Chem Biol Interact; 2008 Sep; 175(1-3):298-302. PubMed ID: 18555980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder].
    Tada M; Fujita N; Umeda M; Koike H; Nagai H
    No To Shinkei; 2004 May; 56(5):415-9. PubMed ID: 15279199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patients confined in bed for an extended period and developing cholinergic crisis following administration of distigmine bromide: report of 3 cases].
    Tadara R; Kobayashi M; Nakamura N; Suzuki Y; Isono S
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1566-7. PubMed ID: 9780688
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of cholinesterases in a young and healthy middle-European population: Relevance for toxicology, pharmacology and clinical praxis.
    Karasova JZ; Maderycova Z; Tumova M; Jun D; Rehacek V; Kuca K; Misik J
    Toxicol Lett; 2017 Aug; 277():24-31. PubMed ID: 28465191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.